From Chemical to Drug
19.12.2016 | Alumni Chapter New England
Von: Patrick Anquetil
The Alumni from New England Chapter were invited to attend a seminar organized by JLABS around drug discovery and development: From Chemical to Drug - The Path to a Small Molecule IND.
Dieser Text ist nicht übersetzt. Hier finden Sie den ganzen Artikel in Englisch.
JLABS is part of Johnson & Johnson Innovation, LLC, and is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. Industry experts from Johnson & Johnson presented best practices when filing small molecule investigational new drug applications. ETH Alumnus Daniel Schaufelberger, Sr. Scientific Director, Portfolio Management, Janssen R&D, and lead coordinator of the ETH Alumni North America Chapters helped organize the event and presented a talk explaining the method of drug development. The event was well attended and a captivated audience asked pertinent questions on how to reduce this knowledge to practice.